Skip to main content

PSA Nadir 2 Years After Definitive SBRT for Prostate Cancer: Predictors of Absolute PSA Decline

Blacksburg, M.D.
Seth
Radiation Oncology
NYU Winthrop Hospital
New York
NY
USA
Show all authors
Sheu, PhD.
Rendi
Radiation Oncology
Icahn School of Medicine at Mount Sinai
New York
NY
USA
Demircioglu, M.A.
Gizem
Radiation Oncology
NYU Winthrop Hospital
New York
NY
USA
Mirza, R.T.T.
Awais
Radiation Oncology
NYU Winthrop Hospital
New York
NY
USA
Carpenter, M.D.
Todd
Radiation Oncology
NYU Winthrop Hospital
New York
NY
USA
Morgenstern, M.S.
Jason
Radiation Oncology
NYU Winthrop Hospital
New York
NY
USA
Witten, PhD.
Matthew
Radiation Oncology
NYU Winthrop Hospital
New York
NY
USA
Mendez, B.A.
Christopher
Radiation Oncology
NYU Winthrop Hospital
New York
NY
USA
Endres, B.S.
Paul
Radiation Oncology
NYU Winthrop Hospital
New York
NY
USA
Katz, M.D.
Aaron
Urology
NYU Winthrop Hospital
New York
NY
USA
Haas, M.D.
Jonathan
Radiation Oncology
NYU Winthrop Hospital
New York
NY
USA

Tabs

Speciality: 
Radiotherapy
Keywords: 
SBRT, Prostate cancer, Nadir PSA, PSA, PSA predictors